P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials
![P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/2a299f30-d123-45a6-b68a-c12d3a79d86d/fx1.jpg)
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events | Journal of the American College of Cardiology
![PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d0d1a9da91bb2852125f3fe77a8eb24002b62415/6-Figure1-1.png)
PDF] Aspirin: Its risks, benefits, and optimal use in preventing cardiovascular events | Semantic Scholar
![Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates](https://sa1s3optim.patientpop.com/assets/images/provider/photos/2500811.jpg)
Understanding the New 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease | Cardiologists located in Cypress, Katy, Houston, Sealy and Fulshear, TX | Memorial Katy Cardiology Associates
![Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109722057205-fx1.jpg)
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes - ScienceDirect
![Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/a7ac3f13-0704-4b82-816b-320a46ef5568/fx1.jpg)
Aspirin for Primary Prevention of Cardiovascular Events | Journal of the American College of Cardiology
![Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com](https://cf-images.us-east-1.prod.boltdns.net/v1/static/5270290550001/5bbb74cb-7e33-4967-b8ae-3920861b2bfb/645f7114-e2c7-45e0-9e62-a5b254e4b1d8/1280x720/match/image.jpg)
Aspirin Use for Primary Secondary Prevention: Critical Appraisal of What We Know and What We Don't | tctmd.com
![2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram 2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram](https://www.researchgate.net/publication/348259767/figure/fig1/AS:977975415681024@1610178917739/The-use-of-aspirin-for-primary-and-secondary-prevention-of-CAD-161.png)
2 The use of aspirin for primary and secondary prevention of CAD [161] | Download Scientific Diagram
![Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109720344260-fx1.jpg)
Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar - ScienceDirect
![Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet](https://www.thelancet.com/cms/attachment/931adf73-9ae4-4f8b-ad58-338cc353792e/gr1.gif)
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis - The Lancet
![Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -) Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings | Irish Journal of Medical Science (1971 -)](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11845-021-02649-5/MediaObjects/11845_2021_2649_Fig1_HTML.png)